Clinical trial

INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi

NCT04945070

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-07-01

PhasePHASE4

Study timeline

Study start (estimated)2021-07-01Date precision: month

Registry last updated2021-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Treated With Insulinunresolved

Interventions

IGlarLixiDRUG

MDI - Multiple dose insulin injectionDRUG

Sponsors & collaborators

Institute for Clinical and Experimental Medicinelead sponsor

Mapped research locations

PragueCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04945070 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.